Effect of Deep Neuromuscular Block on Surgical Conditions in Morbidly Obese Patients (BLISS3)
Effect of Depth of Neuromuscular Block on Intraoperative Surgical Conditions as Determined by the Leiden Surgical Rating Scale in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery
Sponsor: Leiden University Medical Center
Listed as NCT02553629, this PHASE4 trial focuses on Surgical Conditions and remains completed. Sponsored by Leiden University Medical Center, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jun 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jun 2022 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Leiden University Medical Center
- Medical Center Haaglanden
- Merck Sharp & Dohme LLC
For direct contact, visit the study record on ClinicalTrials.gov .